In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk.
Level V
Where this comes from
- Record sourced from PubMed, PMID 33395342.
- Also identified by DOI 10.7326/ACPJ202101190-009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Black DM, Geiger EJ, Eastell R, et al. <b>Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates.</b> N Engl J Med. 2020;383:743-53. 32813950.
Medical subject headings
- Femoral Fractures
- Osteoporotic Fractures